Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Neural scene representation and rendering.

Eslami SMA, Jimenez Rezende D, Besse F, Viola F, Morcos AS, Garnelo M, Ruderman A, Rusu AA, Danihelka I, Gregor K, Reichert DP, Buesing L, Weber T, Vinyals O, Rosenbaum D, Rabinowitz N, King H, Hillier C, Botvinick M, Wierstra D, Kavukcuoglu K, Hassabis D.

Science. 2018 Jun 15;360(6394):1204-1210. doi: 10.1126/science.aar6170.

PMID:
29903970
2.

Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages.

Mommert S, Gregor K, Rossbach K, Schaper K, Witte T, Gutzmer R, Werfel T.

J Allergy Clin Immunol. 2018 Feb;141(2):782-785.e5. doi: 10.1016/j.jaci.2017.06.023. Epub 2017 Jul 18. No abstract available.

PMID:
28728999
3.

Sweat pore reactivity as a surrogate measure of sympathetic nervous system activity in trauma-exposed individuals with and without posttraumatic stress disorder.

Familoni BO, Gregor KL, Dodson TS, Krzywicki AT, Lowery BN Jr, Orr SP, Suvak MK, Rasmusson AM.

Psychophysiology. 2016 Sep;53(9):1417-28. doi: 10.1111/psyp.12681. Epub 2016 Jun 11.

PMID:
27286885
4.

Deployment stress, tobacco use, and postdeployment posttraumatic stress disorder: Gender differences.

Japuntich SJ, Gregor K, Pineles SL, Gradus JL, Street AE, Prabhala R, Rasmusson AM.

Psychol Trauma. 2016 Mar;8(2):123-6. doi: 10.1037/tra0000093. Epub 2015 Dec 14.

PMID:
26654688
5.

Does guilt mediate the association between tonic immobility and posttraumatic stress disorder symptoms in female trauma survivors?

Bovin MJ, Dodson TS, Smith BN, Gregor K, Marx BP, Pineles SL.

J Trauma Stress. 2014 Dec;27(6):721-4. doi: 10.1002/jts.21963. Epub 2014 Nov 10.

PMID:
25385521
6.

The shared neuroanatomy and neurobiology of comorbid chronic pain and PTSD: therapeutic implications.

Scioli-Salter ER, Forman DE, Otis JD, Gregor K, Valovski I, Rasmusson AM.

Clin J Pain. 2015 Apr;31(4):363-74. doi: 10.1097/AJP.0000000000000115. Review.

PMID:
24806468
7.

Psychophysiologic reactivity, subjective distress, and their associations with PTSD diagnosis.

Pineles SL, Suvak MK, Liverant GI, Gregor K, Wisco BE, Pitman RK, Orr SP.

J Abnorm Psychol. 2013 Aug;122(3):635-44. doi: 10.1037/a0033942. Erratum in: J Abnorm Psychol. 2015 May;124(2):287.

PMID:
24016006
8.

The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia.

Ahnallen CG, Liverant GI, Gregor KL, Kamholz BW, Levitt JJ, Gulliver SB, Pizzagalli DA, Koneru VK, Kaplan GB.

Psychiatry Res. 2012 Mar 30;196(1):9-14. doi: 10.1016/j.psychres.2011.09.011. Epub 2012 Feb 17.

9.

Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).

Watterson SH, Langevine CM, Van Kirk K, Kempson J, Guo J, Spergel SH, Das J, Moquin RV, Dyckman AJ, Nirschl D, Gregor K, Pattoli MA, Yang X, McIntyre KW, Yang G, Galella MA, Booth-Lute H, Chen L, Yang Z, Wang-Iverson D, McKinnon M, Dodd JH, Barrish JC, Burke JR, Pitts WJ.

Bioorg Med Chem Lett. 2011 Dec 1;21(23):7006-12. doi: 10.1016/j.bmcl.2011.09.111. Epub 2011 Oct 5.

PMID:
22018461
10.

Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: the importance of tracking idiographic change.

Busch AM, Wagener TL, Gregor KL, Ring KT, Borrelli B.

Addict Behav. 2011 Dec;36(12):1228-32. doi: 10.1016/j.addbeh.2011.07.031. Epub 2011 Jul 30.

11.

Barriers to quitting smoking among medically ill smokers.

Gregor K, Borrelli B.

J Behav Med. 2012 Oct;35(5):484-91. doi: 10.1007/s10865-011-9376-y. Epub 2011 Aug 18.

PMID:
21850514
12.

Differences in smoking behavior and attitudes among Puerto Rican, Dominican, and non-Latino white caregivers of children with asthma.

Borrelli B, Hayes RB, Gregor K, Lee CS, McQuaid EL.

Am J Health Promot. 2011 May-Jun;25(5 Suppl):S91-5. doi: 10.4278/ajhp.100624-ARB-214.

13.

Risk perception in smokers with children with asthma.

Wagener TL, Gregor KL, Busch AM, McQuaid EL, Borrelli B.

J Consult Clin Psychol. 2010 Dec;78(6):980-5. doi: 10.1037/a0021094.

14.

Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.

Gillooly KM, Pattoli MA, Taylor TL, Chen L, Cheng L, Gregor KR, Whitney GS, Susulic V, Watterson SH, Kempson J, Pitts WJ, Booth-Lute H, Yang G, Davies P, Kukral DW, Strnad J, McIntyre KW, Darienzo CJ, Salter-Cid L, Yang Z, Wang-Iverson DB, Burke JR.

J Pharmacol Exp Ther. 2009 Nov;331(2):349-60. doi: 10.1124/jpet.109.156018. Epub 2009 Aug 3.

15.

Perceived physical health and heart-focused anxiety among daily adult cigarette smokers: associations with affect-relevant smoking motives and outcome expectancies.

Leyro TM, Zvolensky MJ, Vujanovic AA, Johnson K, Gregor K.

Cogn Behav Ther. 2010;39(1):11-23. doi: 10.1080/16506070902767621.

PMID:
19639483
16.

Panic reactivity to voluntary hyperventilation challenge predicts distress tolerance to bodily sensations among daily cigarette smokers.

Marshall EC, Zvolensky MJ, Vujanovic AA, Gregor K, Gibson LE, Leyro TM.

Exp Clin Psychopharmacol. 2008 Aug;16(4):313-21. doi: 10.1037/a0012752.

17.

Impact of Posttraumatic Stress Disorder on early smoking lapse and relapse during a self-guided quit attempt among community-recruited daily smokers.

Zvolensky MJ, Gibson LE, Vujanovic AA, Gregor K, Bernstein A, Kahler C, Legues CW, Brown RA, Feldner MT.

Nicotine Tob Res. 2008 Aug;10(8):1415-27. doi: 10.1080/14622200802238951.

PMID:
18686190
18.
19.

Anxiety sensitivity and perceived control over anxiety-related events: associations with smoking outcome expectancies and perceived cessation barriers among daily smokers.

Gregor KL, Zvolensky MJ, McLeish AC, Bernstein A, Morissette S.

Nicotine Tob Res. 2008 Apr;10(4):627-35. doi: 10.1080/14622200801978706.

PMID:
18418785
20.

Evaluation of smoking characteristics among community-recruited daily smokers with and without posttraumatic stress disorder and panic psychopathology.

Marshall EC, Zvolensky MJ, Vujanovic AA, Gibson LE, Gregor K, Bernstein A.

J Anxiety Disord. 2008 Oct;22(7):1214-26. doi: 10.1016/j.janxdis.2008.01.003. Epub 2008 Jan 11.

21.

Incremental validity of anxiety sensitivity in terms of motivation to quit, reasons for quitting, and barriers to quitting among community-recruited daily smokers.

Zvolensky MJ, Vujanovic AA, Miller MO, Bernstein A, Yartz AR, Gregor KL, McLeish AC, Marshall EC, Gibson LE.

Nicotine Tob Res. 2007 Sep;9(9):965-75.

PMID:
17763114
22.

Concurrent associations between anxiety sensitivity and perceived health and health disability among young adult daily smokers.

McLeish AC, Zvolensky MJ, Smits JA, Bonn-Miller MO, Gregor KL.

Cogn Behav Ther. 2007;36(1):1-11.

PMID:
17364647
23.

Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.

Beaulieu F, Ouellet C, Ruediger EH, Belema M, Qiu Y, Yang X, Banville J, Burke JR, Gregor KR, MacMaster JF, Martel A, McIntyre KW, Pattoli MA, Zusi FC, Vyas D.

Bioorg Med Chem Lett. 2007 Mar 1;17(5):1233-7. Epub 2006 Dec 9.

PMID:
17197177
24.

Violence against pregnant women in Northwestern Ontario.

Tan JC, Gregor KV.

Ann N Y Acad Sci. 2006 Nov;1087:320-38.

PMID:
17189514
25.

Smoking motives in the prediction of affective vulnerability among young adult daily smokers.

Gregor K, Zvolensky MJ, Bernstein A, Marshall EC, Yartz AR.

Behav Res Ther. 2007 Mar;45(3):471-82. Epub 2006 May 19.

PMID:
16712784
26.

Perceived health: a test of incremental validity in relation to smoking outcome expectancies, motivation to smoke and desire to quit smoking.

Gregor K, Zvolensky MJ, Leen-Feldner EW, Yartz AR, Feldner MT.

Cogn Behav Ther. 2006;35(1):28-42.

PMID:
16500775
27.

Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: a test of incremental predictive validity among young adult regular smokers.

Zvolensky MJ, Feldner MT, Leen-Feldner EW, Gibson LE, Abrams K, Gregor K.

Behav Res Ther. 2005 Dec;43(12):1683-700.

PMID:
16239158
28.
29.
30.

Health perception is a unique predictor of anxiety symptoms in non-clinical participants.

Yartz AR, Zvolensky MJ, Gregor K, Feldner MT, Leen-Feldner EW.

Cogn Behav Ther. 2005;34(2):65-74.

PMID:
15986782
31.

Anxiety sensitivity: Concurrent associations with negative affect smoking motives and abstinence self-confidence among young adult smokers.

Zvolensky MJ, Bonn-Miller MO, Feldner MT, Leen-Feldner E, McLeish AC, Gregor K.

Addict Behav. 2006 Mar;31(3):429-39. Epub 2005 Jun 16.

PMID:
15964151
32.

Dipolar spin correlations in classical pyrochlore magnets.

Isakov SV, Gregor K, Moessner R, Sondhi SL.

Phys Rev Lett. 2004 Oct 15;93(16):167204. Epub 2004 Oct 14.

PMID:
15525027
33.

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.

Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, Rodríguez MJ, Rele R, Orta J, Kharbeng A, Araya S, Gervin M, Alonso J, Mavreas V, Lavrentzou E, Liontos N, Gregor K, Jones PB; SOHO Study Group.

Acta Psychiatr Scand Suppl. 2003;(416):16-23.

PMID:
12755850
34.

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.

Haro JM, Edgell ET, Jones PB, Alonso J, Gavart S, Gregor KJ, Wright P, Knapp M; SOHO Study Group.

Acta Psychiatr Scand. 2003 Mar;107(3):222-32.

PMID:
12580830
35.

BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y, Zusi FC.

J Biol Chem. 2003 Jan 17;278(3):1450-6. Epub 2002 Oct 25.

37.

BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.

Burke JR, Davern LB, Stanley PL, Gregor KR, Banville J, Remillard R, Russell JW, Brassil PJ, Witmer MR, Johnson G, Tredup JA, Tramposch KM.

J Pharmacol Exp Ther. 2001 Jul;298(1):376-85.

38.

Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.

Springer DM, Luh BY, Bronson JJ, McElhone KE, Mansuri MM, Gregor KR, Nettleton DO, Stanley PL, Tramposch KM.

Bioorg Med Chem. 2000 May;8(5):1087-109.

PMID:
10882020
40.

[Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France].

Le Pen C, Lilliu H, Allicar MP, Olivier V, Gregor KJ.

Encephale. 1999 Jul-Aug;25(4):281-6. French.

PMID:
10546082
41.

Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine.

Edgell ET, Gregor KJ, Cockburn I.

Clin Ther. 1999 May;21(5):917-30. No abstract available.

PMID:
10397385
42.

Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayer.

Burke JR, Witmer MR, Zusi FC, Gregor KR, Davern LB, Padmanabha R, Swann RT, Smith D, Tredup JA, Micanovic R, Manly SP, Villafranca JJ, Tramposch KM.

J Biol Chem. 1999 Jul 2;274(27):18864-71.

43.

Differentiation of U937 cells enables a phospholipase D-dependent pathway of cytosolic phospholipase A2 activation.

Burke JR, Davern LB, Gregor KR, Owczarczak LM.

Biochem Biophys Res Commun. 1999 Jun 24;260(1):232-9.

PMID:
10381372
44.

Concomitant therapy with anxiolytics or hypnotics and maintenance of initial SSRI therapy.

Shields SA, Gregor KJ, Young CH, James SP.

Pharmacotherapy. 1998 Nov-Dec;18(6):1298-303.

PMID:
9855330
45.

Selective serotonin reuptake inhibitor utilization patterns: consistency across research designs.

Hutchins DS, Klein EG, Signa WF, Young CH, Gregor KJ.

Clin Ther. 1998 Jul-Aug;20(4):797-805.

PMID:
9737838
46.

Outpatient antidepressant utilization in a Dutch sick fund.

Gregor KJ, Hylan TR, van Dijk PC, Sier F, Quik R, Kleintjens HT, Kloppenburg T, Young CH.

Am J Manag Care. 1998 Aug;4(8):1150-60.

47.

A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interface.

Burke JR, Gregor KR, Padmanabha R, Banville J, Witmer MR, Davern LB, Manly SP, Tramposch KM.

J Enzyme Inhib. 1998 Jun;13(3):195-206.

PMID:
9629537
48.

Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.

Burke JR, Davern LB, Gregor KR, Tramposch KM.

Biochim Biophys Acta. 1997 Oct 30;1359(1):80-8.

50.

Phosphorylation and calcium influx are not sufficient for the activation of cytosolic phospholipase A2 in U937 cells: requirement for a Gi alpha-type G-protein.

Burke JR, Davern LB, Gregor KR, Todderud G, Alford JG, Tramposch KM.

Biochim Biophys Acta. 1997 Sep 5;1341(2):223-37.

PMID:
9357962

Supplemental Content

Loading ...
Support Center